1,25-Dihydroxyvitamin D3 stimulates phagocytosis but suppresses HLA-DR and CD13 antigen expression in human mononuclear phagocytes

Proceedings of the Society for Experimental Biology and Medicine

Volumn 211, Issue 3, 1996, Pages 244-250

  Tokuda, Noriaki ^a   Levy, Robert B ^b  

^a KYUSHU UNIVERSITY   (Japan)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

24,25 DIHYDROXYCOLECALCIFEROL; CALCITRIOL; CALCITRIOL RECEPTOR; CD33 ANTIGEN; DRUG METABOLITE; HLA ANTIGEN CLASS 2; HLA DR ANTIGEN; INDOMETACIN; MICROSOMAL AMINOPEPTIDASE; MONOCLONAL ANTIBODY; PROSTAGLANDIN E2; TACALCITOL;

ANTIGEN EXPRESSION; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; LYMPHOID CELL; MONOCYTE; PHAGOCYTE; PHAGOCYTOSIS;

EID: 0029670533     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.3181/00379727-211-43967     Document Type: Article

References (39)

1. 3 receptor in bovine thymus gland. Biochem Biophys Res Commun 106:1012-1018, 1982.
2. 3 receptors in human leukocytes. Science 221:1181-1183, 1983.
3. Haussler MR. Vitamin D receptors: Nature and function. Annu Rev Nutr 6:527-562, 1986.
4. Reichel H, Koeffler HP, Norman AW. The role of the vitamin D endocrine system in health and disease. N Engl J Med 320:980-991, 1989.
5. 3. J Clin Invest 79:1659-1664, 1987.
6. 3-binding macromolecules in human B lymphocytes: Effects on immunoglobulin production. J Immunol 136:2734-2740, 1986.
7. 3 inhibits γ-interferon synthesis by normal human peripheral blood lymphocytes. Proc Natl Acad Sci 84:3385-3389, 1987.
8. 3 modulates the expression of a lymphokine (granulocyte-macrophage colony-stimulating factor) posttranscriptionally. J Clin Invest 81:1819-1823, 1988.
9. 3-treated monocytes. Arthritis Rheum 35:110-119, 1995.
10. 3. Blood 76:189-197, 1990.
11. 3, gamma interferon, and control of proliferation of mycobacterium tuberculosis by human monocytes. Immunology 57:159-163, 1986.
12. 3 activates secretion of hydrogen peroxide by human monocytes. J Immunol 136:1049-1053, 1986.
13. 3 maintains adherence of human monocytes and protects them from thermal injury. J Clin Invest 77:1332-1339, 1986.
14. 3. J Clin Endocrinol Metab 69:127-133, 1989.
15. 3 antagonizes interferon-gamma-induced expression of class II major histocompatibility antigens on epithelial and interstitial cells. Endocrinology 127:1419-1427, 1990.
16. 3 down regulation of HLA-DR on human peripheral blood monocytes. Immunology 75:349-356, 1992.
17. Tokuda N, Mano T, Levy RB. Phagocytosis by the murine testicular TM4 sertoli cell line in culture. J Immunol 147:278-282, 1992.
18. Snyder DS, Beller DI, Unanue ER. Prostaglandins modulate macrophage Ia expression. Nature 299:163-165, 1982.
19. 3 on human lymphocytes and monocyte/ macrophages: Inhibition of interleukin 2 and augmentation of interleukin 1 production. Cell Immunol 96:311, 1986.
20. Griffin JD, Lynch D, Sabbath K, Larcom P, Schlossman SF. A monoclonal antibody reactive with normal and leukemic human myeloid progenitor cells. Leuk Res 8:521-534, 1984.
21. Griffin JD, Ritz J, Nadler LM, Schlossman SF. Expression of myeloid differentiation antigens on normal and malignant myeloid cells. J Clin Invest 68:932-941, 1981.
22. Coquette A, Boeynaems JM, Vray B. Eicosanoids modulate CR1-and Fc-dependent bacterial phagocytosis. Eur J Pharmacol 226:1-4, 1992.
23. Knight J, Lloyd-Evans P, Barrow SE. Effect of lipoxins and other eicosanoids on phagocytosis and intracellular calcium mobilization in rainbow trout leukocytes. J Leukoc Biol 54:518-522, 1995.
24. 3 decreases expression of HLA class I molecules in a melanoma cell line. J Immunol 140:4013-4018, 1988.
25. 3 decreases the interferon-γ (IFN-γ) induced HLA-DR expression but not intercellular adhesion molecule 1 (ICAM-1) on human keratinocytes. Reg Immunol 3:223-227, 1991.
26. 3. J Immunol 136:2181-2190, 1986.
27. Mason RS, Lissner D, Grunstein HS, Posen S. A simplified assay for dihydroxylated vitamin D metabolites in human serum: Application to hyper- and hypovitaminosis D. Clin Chem 26:444-450, 1980.
28. Look AT, Ashmun RA, Shapiro LH, Peiper SC. Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase N. J Clin Invest 83:1299-1307, 1989.
29. Griffin JD, Todd RF III, Ritz J, Nadler LM, Canellos GP, Rosenthal D, Gallivan M, Beveridge RP, Weinstein H, Karp D, Schlossman SF. Differentiation patterns in the blastic phase of chronic myeloid leukemia. Blood 61:85-91, 1983.
30. Connell PJ, Gerkis V, d'Apice AJF. CD13: A signal transduction molecule on myeloid cells? Trans Proc 21:3826-3827, 1989.
31. Fertsch D, Schoenberg DR, Germain RN, Tou JY, Vogel SN. Induction of macrophage Ia antigen expression by rIFN-G and down-regulation by IFN-α/β and dexamethasone are mediated by changes in steady-stage levels of Ia mRNA. J Immunol 139:244-249, 1987.
32. Fertsch-Ruggio D, Schoenberg DR, Vogel SN. Induction of macrophage Ia antigen expression by rIFN-γ and downregulation by IFN-α/β and dexamethasone are regulated transciptionally. J Immunol 141:1582-1589, 1988.
33. Lu CY, Changelian PS, Unanue ER. α-Fetoprotein inhibits macrophage expression of Ia antigens. J Immunol 132:1722-1727, 1984.
34. Koerner TJ, Hamilton TA, Adams DO. Suppressed expression of surface Ia on macrophages by lipopolysaccharide: Evidence for regulation at the level of accumulation of mRNA. J Immunol 139:239-243, 1987.
35. Steeg PS, Johnson HM, Oppenheim JJ. Regulation of murine macrophage Ia antigen expression by an immune interferon-like lymphokine: Inhibitory effect of endotoxin. J Immunol 129:2402-2406, 1982.
36. Lewis GP. Immunoregulatory activity of metabolites of arachidonic acid and their role in inflammation. Br Medical Bull 39:243-248, 1983.
37. Yem AW, Parmely MJ. Modulation of Ia-like antigen expression and antigen-presenting activity of human monocytes by endotoxin and zymosan A. J Immunol 127:2245-2251, 1981.
38. Unanue ER, Beller DI, Lu CY, Allen PM. Antigen presentation: Comments on its regulation and mechanism. J Immunol 132:1-5, 1984.
39. Janeway CA, Bottomly K, Babich J, Conrad P, Conzen S, Jones B, Kaye J, Katz M, McVay I, Murphy DB, Tite J. Quantitative variation in Ia antigen expression plays a central role in immune regulation. Immunol Today 5:99-105, 1984.